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Abstract
Physicians treating newly incapacitated patients often must help navigate surrogate decision-makers
through a difficult course of treatment decisions, while safeguarding the patient's autonomy. We offer
guidance for intensive care physicians who must frequently address the difficult questions concerning
disclosure of confidential information to surrogates. Three clinical vignettes will highlight the ethical
challenges to physician disclosure of a critically ill patient's HIV status. Two key distinctions are offered
that influence the propriety of disclosure: first, whether HIV infection represents a 'primary cause' for the
patient's critical illness; and second, whether the surrogate may be harmed by failure to disclose HIV
status. This balanced consideration of the direct duties of physicians to patients, and their indirect duties
to surrogates and third-party contacts, may be used as a framework for considering other ethical
obligations in the intensive care unit. We also provide a tabulation of individual US state laws relevant to
disclosure of HIV status.
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Abstract

fever, chills, fatigue, and shortness of breath. Her blood
cultures rapidly grow Staphylococcus aureus, and an
echocardiogram is consistent with bacterial endocarditis.
Septic shock and the acute respiratory distress syndrome
develop. Prior to intubation, the patient asks that her daughter
be her surrogate decision-maker, but that her daughter not be
informed of the patient’s HIV status. The patient’s husband
had died eight months earlier from an AIDS-related illness.

Physicians treating newly incapacitated patients often must help
navigate surrogate decision-makers through a difficult course of
treatment decisions, while safeguarding the patient’s autonomy.
We offer guidance for intensive care physicians who must
frequently address the difficult questions concerning disclosure of
confidential information to surrogates. Three clinical vignettes will
highlight the ethical challenges to physician disclosure of a
critically ill patient’s HIV status. Two key distinctions are offered
that influence the propriety of disclosure: first, whether HIV
infection represents a ‘primary cause’ for the patient’s critical
illness; and second, whether the surrogate may be harmed by
failure to disclose HIV status. This balanced consideration of the
direct duties of physicians to patients, and their indirect duties to
surrogates and third-party contacts, may be used as a framework
for considering other ethical obligations in the intensive care unit.
We also provide a tabulation of individual US state laws relevant to
disclosure of HIV status.

Introduction
Physicians treating newly incapacitated patients often must
help navigate surrogate decision-makers through a difficult
course of treatment decisions [1]. Because safeguarding the
patient’s autonomy often requires open discussion of the
patient’s condition with appointed surrogates [2,3], physicians
have ethical duties to provide surrogates with complete and
accurate information on which to base their decisions.
But how exacting are these duties? Under what circumstances, if any, may physicians intentionally withhold information
about the incapacitated patient from surrogates? In this
commentary, we use three cases as examples to guide intensive
care physicians in addressing these difficult questions.

Clinical cases
Case 1
A 45 year old HIV-positive woman with an unknown CD4
count is admitted to an intensive care unit with 3 days of

Case 2
A 48 year old man presents with acute hypoxemic respiratory
failure requiring immediate intubation. The patient has
advanced HIV disease complicated by AIDS wasting
syndrome, disseminated candidiasis, and pulmonary hypertension, all of which have contributed to his poor functional
status at baseline. He has declined antiretroviral therapy, has
kept the source of his symptoms to himself, has never
disclosed his HIV status to his living relatives, and has not
engaged in sexual activities since he was diagnosed.

Despite initiating therapy with trimethoprim/sulfamethoxazole
and glucocorticoids for Pneumosistis jiroveci pneumonia, the
patient remains intubated and critically ill several weeks later.
The physicians estimate that the patient’s poor nutritional
status and severe respiratory compromise make meaningful
recovery highly unlikely. They ask the patient’s next-of-kin to
clarify the patient’s wishes for aggressive care.
Case 3
A 55 year old HIV-positive woman with known severe chronic
obstructive pulmonary disease presents with acute hypercarbic respiratory failure and requires urgent intubation. Prior
to intubation, she asks the physician not to tell her husband
that she is HIV-positive, expressing concern that he would
hate her for being dishonest with him, and for putting him at
risk during intercourse.
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The ethical conflicts
The patient in case 1 is critically ill due to several disease
processes, which may or may not have been linked to her
immunocompromised state. She poses no direct risk to her
decision-maker. The patient in case 2 is critically ill due to a
known complication of advanced HIV, and the patient’s prior
choices to forgo therapy for this disease may reflect the
patient’s underlying values and preferences for end-of-life
care. Finally, the patient in case 3 is critically ill for reasons
not clearly related to HIV, but her HIV disease is relevant
because she has been sexually active with her surrogate
decision-maker.

Importantly, failure to disclose the patient’s underlying health
condition risks minimizing opportunities for the timely
withdrawal of painful or futile interventions. The physicians’
obligation of beneficence to their patients is therefore
relevant to the decision to disclose because doing so may
ultimately serve the patients’ interests in avoiding needless
suffering [5]. In general, disclosure is justified when: the
patient is at significant risk of unnecessary suffering; the
action of others is needed to prevent this suffering; the action
of others has a high probability of preventing it; and the
benefit that the patient can be expected to gain outweighs
any harms, costs, or burdens that others are likely to incur.

In case 1, the physicians ideally would have obtained more
information regarding the patient’s treatment preferences prior
to intubation. However, because patients may be unprepared
or unable to have such a discussion while acutely ill,
surrogates often provide the best information physicians can
obtain to guide future management. When a pre-existing
surrogate, or one with durable power of attorney for health
care, is not available, physicians must often ascertain whether
a newly designated surrogate is suitable. Specifically, a proper
surrogate will: have an appropriate familial or otherwise legally
recognized relationship to the patient; be capable of
ascertaining and effectuating the patient’s wishes and best
interests; and not act from improper or personal motives.

In addition, disclosure may be justified on legal and ethical
grounds if nondisclosure poses a direct and foreseeable risk
to the surrogate. In case 3, for example, failure to disclose the
patient’s HIV status to the husband may forestall his timely
testing for a life-threatening but treatable infection. The
Tarasoff case established that confidentiality must be
breached if there is an imminent threat to an identifiable third
party, or “the duty to warn” [6]. In case 3, privileging the HIVpositive wife by viewing her entitlement to confidentiality as
unimpeachable, regardless of the potential harm to her
husband, and possibly others through him, is unjust because
it inappropriately places her rights above those of her
husband.

Though many critically ill patients lack proper surrogates [4],
when they exist, physicians are obliged to provide them with
all relevant information about the patient’s medical condition
so that the surrogate can make an informed decision on the
patient’s behalf. Information about specific underlying
diseases may be relevant to a proper consideration of the
patient’s current condition if it clarifies why the patient’s
condition is or is not potentially reversible, or if knowledge of
how the patient previously chose to deal with this disease
can clarify the patient’s underlying values or beliefs.

Thus, when nondisclosure places third parties at serious and
foreseeable risk, as for the husband in this case, obligations
to disclose confidential information emerge [6].

In case 1, the physicians did not disclose the patient’s HIV
status to the daughter because the HIV infection was merely
one of many potential reasons why the patient may have been
so ill. Disclosure would not have enabled the daughter to
better serve her role as surrogate decision-maker. Nondisclosure upheld both the physicians’ duty to maintain the
patient’s confidentiality, and their duty to the surrogate to
provide all necessary information to make an informed
decision that served the patient’s interests.
By contrast, in case 2, the father’s HIV infection was a
proximate determinant of his current clinical condition, and
knowledge of how he previously chose to respond to this illness
might usefully inform the daughter’s consideration of how he
would want to be managed in his current condition. Thus,
disclosure of the father’s severe HIV-related illnesses, and his
prior choices to forgo therapy, may improve the daughter’s
ability to act as an appropriate surrogate in this case.
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Physicians disclosing such information must do so cautiously,
however, because it is possible that surrogates may respond
to such information with anger or resentment at not having
been informed previously by the patients. In such cases,
disclosure may impair the surrogate’s ability to make
decisions on the patient’s behalf. If such impairment of a
surrogate’s decisional capacity is foreseen by the physician, it
may be necessary to involve other family members, or even a
court-appointed guardian, in discussions regarding the
patient’s medical care.

Conclusions
Disclosure of confidential information to surrogate decisionmakers of critically ill patients is justified under a narrow set of
conditions. These conditions are limited to cases in which
disclosure is necessary for the surrogate to make decisions
that reflect the patient’s values and interests, or when failure
to disclose poses direct and foreseeable risks to the
surrogate. We believe this ethical framework, exemplified by
the foregoing cases, should guide physicians faced with such
dilemmas in the intensive care unit. However, in several US
states, established case law may also influence physicians’
practices [7-14]. Although most states have not adopted
specific statutes governing disclosure of confidential HIVrelated information, some have adopted laws that: prohibit
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Table 1
Laws of the 53 US states and territories: physician’s disclosure of a patient’s HIV statusa
Physician
notification
to a third party

No. of states
(percent)

States

Requiredb

1 (1)

Permittedc

10 (19)

Arizona, California, Iowa, Kentucky, Massachusetts, New York, Pennsylvania, Rhode Island,
South Carolina, Texas

Prohibitedd

11 (21)

Alaska, Arkansas, Washington, DC, Georgia, Hawaii, Idaho, Mississippi, Puerto Rico,
South Dakota, Vermont, Virginia

No guidelinese

31 (59)

Alabama, Colorado, Connecticut, Delaware, Florida, Illinois, Indiana, Kansas, Louisiana, Maine,
Maryland, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey,
New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Tennessee, Utah,
Virgin Islands, Washington, West Virginia, Wisconsin, Wyoming

Michigan

aIncludes all 50 US states, District of Columbia, Puerto Rico, and the Virgin Islands. bThe state law contains a specific statement that a health care
provider (not a health agency) has a duty to disclose a patient’s HIV status to at risk third parties under certain circumstances (for example, when
the infected index patient refuses to disclose such information, or as long as the anonymity of the index patient is maintained). cThe state law
neither requires nor prohibits but does allow a health care provider to disclose a patient’s HIV status to at risk third parties (certain restrictions may
apply, such as a requirement that physicians first encourage the index patient to disclose their status themselves). dThe state law contains a
specific statement that a health care provider may not notify at risk third parties of a patient’s HIV status. States encourage or allow court-ordered
testing for HIV or third-party notification of a patient’s HIV status in cases of sexual assault; however, these states also prohibit such practices in
other cases, and are classified as prohibiting physician disclosure. eThere are no specific state laws regarding a physician’s disclosure of a
patient’s HIV status to at risk third parties. States make no general comment on third-party notification, but require or prohibit it in cases of sexual
assault; these are classified as providing no guidelines.

disclosure of HIV status, even when third parties are at risk;
require disclosure in such cases; or permit disclosure in such
cases after considering its risks and benefits [15]. We
summarize these state laws in Table 1 for physicians’ future
reference.
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